The Medical College of Wisconsin, Department of Medicine, Division of Hematology and Oncology, Milwaukee, WI
Ariel Ann Nelson , Christina Ladwig , Kristin Riemersma , Kathryn A. Bylow , Deepak Kilari
Background: AA patients (pts) with pCa tend to have worse outcomes when compared to Caucasians. Disparities in access to healthcare among AA pts with pCa is a significant barrier to improvement in outcomes. Medical oncology visit attendance among this population has not been thoroughly investigated. Methods: Pts with a diagnosis (dx) of pCa scheduled to see a provider (MD or advanced practice provider) at a single academic institution medical oncology clinic between January 2022 and December 2022 were retrospectively identified. Pts were categorized by self-identified race. The total number of scheduled clinic visits was recorded, and each visit was categorized by visit status; completed, cancelled, no-show, or left clinic. The reason for visit cancellation was assessed and cancelled visits for non-pt driven reasons (ie. scheduling error) were removed. The data were summarized using descriptive statistics. Z-test and Chi-square analysis were utilized to compare proportions of visits between AA and Caucasian pts and the association of race with visit status. Results: A total of 992 pts were selected, 80% (n = 792) were Caucasian and 16% (n = 162) were AA, representing 4231 clinic visits during the study period. AA pts accounted 18% (n = 763) of the total scheduled visits. 94% of visits (n = 3962) were follow up and 6% (n = 269) were new pt visits. 86% of all scheduled visits were completed and 10 % (n = 436) were cancelled for pt driven reasons. Roughly 3% (n = 135) of visits were no-show. AA pts had fewer completed visits compared to Caucasian pts, 78% vs 88% (p < 0.001) and a higher no-show rate of 10% vs 1.5% (p < 0.001). The cancellation rate was similar between AA and Caucasian pts, 11% vs 10% (p = 0.33). The combined no-show and cancellation rate for AA pts was 22% vs 12% for Caucasian pts (p < 0.001). There was a significant association between AA race and no-show visit status (p < 0.001). Conclusions: AA men with pCa have much poorer visit adherence to scheduled medical oncology visits compared to their Caucasian counterparts. Identifying reasons for no-show and visit cancellations and targeted interventions to improve access to care are needed to improve outcomes.
Race | Total Scheduled | Completed | No-show | Cancellation | Left Clinic |
---|---|---|---|---|---|
White | 3279 | 2896 | 49 | 331 | 3 |
AA | 763 | 595 | 80 | 88 | 0 |
Asian | 66 | 60 | 0 | 6 | 0 |
American Indian / Native Alaskan | 22 | 18 | 1 | 3 | 0 |
Hawaiian/Pacific Islander | 2 | 0 | 1 | 1 | 0 |
Other | 83 | 72 | 4 | 7 | 0 |
Declined to Answer | 16 | 16 | 0 | 0 | 0 |
Total | 4231 | 3657 | 135 | 436 | 3 |
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Abstract Disclosures
2024 ASCO Annual Meeting
First Author: Phuong Nhi Le
2024 ASCO Genitourinary Cancers Symposium
First Author: Daniel Sabater Minarim
2022 ASCO Quality Care Symposium
First Author: Ambrish Pandit
2024 ASCO Gastrointestinal Cancers Symposium
First Author: Shiva Shrotriya